AnalystsYaron WerberYaron Werber's Stock Forecasts
AnalystsYaron Werber
Sectors:
Industries:
Analyst Ranking
Bottom 13%
#4307 out of 4923 analysts
Average Return
-1.27%
Win Rate
45%15 out of 33
Risk vs Reward
Poor
Good
Yaron Werber's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Exelixis IncEXEL | +78.56% | $21.93 | $39.15 | 2024-04-30 - 2025-04-30 | Strong Buy |
Beone Medicines LtdONC | +72.86% | $144.12 | $249.13 | 2024-04-23 - 2025-04-23 | Strong Buy |
Exelixis IncEXEL | +53.79% | $28.66 | $44.08 | 2024-10-20 - 2025-06-30 | Strong Buy |
Ascendis Pharma AASND | +44.44% | $119.50 | $172.60 | 2024-09-03 - 2025-06-30 | Strong Buy |
Beone Medicines LtdONC | +39.91% | $168.64 | $235.94 | 2024-05-08 - 2025-05-08 | Strong Buy |
Yaron Werber Analyst Color
Get additional color on Yaron Werber's coverage of popular stocks
Yaron Werber's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Springworks Therapeutics IncSWTX | 1 | Hold | $47.00 | +0.02% | Downgrades | 2 months ago |
Beone Medicines LtdONC | 6 | Strong Buy | $334.00 | +37.98% | Reiterates | 2 months ago |
Ascendis Pharma AASND | 5 | Strong Buy | $153.00 | -11.36% | Maintains | 8 months ago |
Biontech SeBNTX | 5 | Hold | $122.00 | +14.59% | Maintains | 8 months ago |
Ultragenyx Pharmaceutical IncRARE | 2 | Strong Buy | $73.00 | +100.77% | Maintains | 8 months ago |
Exelixis IncEXEL | 2 | Strong Buy | $34.00 | -22.86% | Maintains | 8 months ago |
Amgen IncAMGN | 5 | Strong Buy | $383.00 | +37.17% | Maintains | 8 months ago |
Ionis Pharmaceuticals IncIONS | 1 | Strong Buy | $59.00 | +49.33% | Maintains | a year ago |
Legend Biotech CorpLEGN | 2 | Strong Buy | $67.00 | +88.79% | Maintains | a year ago |
Argenx SeARGX | 3 | Buy | $641.00 | N/A | Maintains | 2 years ago |
Fibrogen IncFGEN | 1 | Hold | $625.00 | N/A | Maintains | 2 years ago |
Instil Bio IncTIL | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
Genmab AGMAB | 1 | Hold | $38.00 | N/A | Initiates Coverage On | 3 years ago |
Bluebird Bio IncBLUE | 2 | Hold | N/A | N/A | Downgrades | 3 years ago |
2seventy Bio IncTSVT | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Io Biotech IncIOBT | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Roivant Sciences LtdROIV | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Acceleron Pharma IncXLRN | 1 | Hold | $180.00 | N/A | Downgrades | 4 years ago |
Immuneering CorpIMRX | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Dicerna Pharmaceuticals IncDRNA | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Nuvation Bio IncNUVB | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Regeneron Pharmaceuticals IncREGN | 1 | Buy | $565.00 | N/A | Maintains | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.